about
ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndromeCushing syndrome in pediatricsSomatic HIF2A gain-of-function mutations in paraganglioma with polycythemiaPituitary pathology in Carney complex patientsProtein Kinase A and Anxiety-Related Behaviors: A Mini-ReviewDiagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice GuidelineCarney complex: an updateAlterations of Phosphodiesterases in Adrenocortical TumorsSelective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomasCyclic AMP-dependent signaling aberrations in macronodular adrenal diseaseGene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediatorsA genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasiaPancreatic ductal and acinar cell neoplasms in Carney complex: a possible new associationGigantism and acromegaly due to Xq26 microduplications and GPR101 mutation.Cushing's syndromeSomatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjectsStromal, fibrous, and fatty gastrointestinal tumors in a patient with a PDGFRA gene mutationNormalized early post-operative cortisol and ACTH values predict nonremission after surgery for Cushing's disease.Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study.Is IGSF1 involved in human pituitary tumor formation?X-linked acrogigantism syndrome: clinical profile and therapeutic responsesPseudotumor cerebri after surgical remission of Cushing's disease.Postoperative testing to predict recurrent Cushing disease in children.The complex of myxomas, spotty skin pigmentation and endocrine overactivity (Carney complex): imaging findings with clinical and pathological correlationEndocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromesProtein kinase A effects of an expressed PRKAR1A mutation associated with aggressive tumors.Comprehensive analysis of LC/MS data using pseudocolor plots.Endocrine abnormalities in patients with Fanconi anemia.Diagnostic tests for children who are referred for the investigation of Cushing syndrome.Serial analysis of gene expression in adrenocortical hyperplasia caused by a germline PRKAR1A mutation.Does somatostatin have a role in the regulation of cortisol secretion in primary pigmented nodular adrenocortical disease (ppnad)? a clinical and in vitro investigation.ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional ConsequencesACTH-independent Cushing's syndrome with bilateral micronodular adrenal hyperplasia and ectopic adrenocortical adenoma.Association of the M1V PRKAR1A mutation with primary pigmented nodular adrenocortical disease in two large families.Cushing's syndrome and fetal features resurgence in adrenal cortex-specific Prkar1a knockout miceWhat is the best criterion for the interpretation of adrenal vein sample results in patients with primary hyperaldosteronism?Known VDR polymorphisms are not associated with bone mineral density measures in pediatric Cushing disease.Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation.KCNJ5 mutations in the National Institutes of Health cohort of patients with primary hyperaldosteronism: an infrequent genetic cause of Conn's syndrome.Familial micronodular adrenocortical disease, Cushing syndrome, and mutations of the gene encoding phosphodiesterase 11A4 (PDE11A).
P50
Q24310286-AA3CACC2-ED95-4EE3-9CDC-18BB292D21F0Q24606619-20F088A5-CFC8-4108-8CFC-BC1F3604F164Q24607557-41F2B5F0-0C3F-40E3-90A8-DD5FAE5EA423Q24647038-1DDCA75C-477F-4D53-A077-CED8340AF005Q26742185-817EAE3F-E759-4B79-B5D9-7C423ACF30EDQ26772152-3192BBC9-E29F-4820-BB89-A055C25801C4Q27026529-CFD9D26F-7805-46CA-AA91-65C8D1427341Q28066278-12219453-F9A3-4257-B20F-3041EF8A6626Q28117410-259CCA16-5620-421C-9780-669A55D5A418Q28214762-436D998F-1019-4DF0-8DE2-4B0449925448Q28242795-1F30A286-D931-4772-BD79-EDBD4220347DQ28245373-851EC81D-3EF3-4CB3-8986-BB49ADC50B79Q28247409-B1A9B429-B9AC-4F01-9507-F0109B3195B9Q28253227-A3606237-F366-48FD-BAEB-063703AE865AQ28262360-28393D7E-C747-42AF-A898-6AAF71CA57D8Q28394993-4D858F0B-8532-41CB-A957-5F9EF67012CDQ28742442-01EA5F2B-5119-411F-AB23-2495226380D7Q30252910-80823215-8242-4CD1-A9BC-7DA5146C0E78Q30276702-1D706FA3-F757-4073-BAEB-9EE63F6CB83AQ30301093-787BEBAF-33C5-4D9F-880B-38AC613CA5C8Q30370618-F5B84E1F-DCCE-4B63-9D67-985BAB2609A2Q30432844-F4A30F05-4717-4627-A0A7-0516491BED7CQ30435318-686386C0-44C8-4DD6-8561-123AAB260D27Q30457896-39F286D8-5918-466B-9680-2B681EE61640Q30475253-4D9B81A5-B9DD-4494-89C4-3C186A5FCE99Q30502101-745D70D8-6D91-448C-A8B6-600F94B3B7E2Q30584218-04DAA88C-D7A5-4D41-A1AE-FEDB1364F55DQ31108898-DA026B05-8013-4C9A-B6B0-EB4C5013AE42Q31121787-185E5F9A-EB25-4381-B6A5-E0568BA11FD3Q33226869-6EFA4071-BA7F-4513-90FB-E6B892A887D2Q33569023-587207D3-C219-4C98-BA5E-C5B019D12CCEQ33570265-645F6DB1-9486-45E2-A540-9234CDE5A039Q33586715-63AE4100-552D-461D-93EE-68B467C403A9Q33586753-5375F018-3759-4897-B9B0-01CE9A0EDA5BQ33604822-75AC27E5-0FD0-4AC5-8421-9E0693CA9D5BQ33664558-3DC9611F-BA5B-417E-AFCD-66D5DCCCC219Q33664581-1DEE2442-A3AA-4804-8354-284407D714E6Q33682397-E4774D4C-2A95-4306-8701-E1D5EDBE3732Q33698924-8896A222-728D-4BBA-A920-B1128CEF2D9AQ33701874-CE37FE38-E071-4AC5-B156-F56E52CBFF2E
P50
subject
name
Constantine A Stratakis
@ast
Constantine A Stratakis
@en
Constantine A Stratakis
@nl
type
label
Constantine A Stratakis
@ast
Constantine A Stratakis
@en
Constantine A Stratakis
@nl
prefLabel
Constantine A Stratakis
@ast
Constantine A Stratakis
@en
Constantine A Stratakis
@nl
P1006
P214
P1006
P214
P31
P7859
lccn-n2002011393